CAH
Cardinal Health·NYSE
--
--(--)
--
--(--)
7.35 / 10
Outperform
Analysts favor CAH with three Buys and one Neutral, averaging a 6.85 weighted rating. Fund flow score 7.85 reflects solid capital inflows, especially from block, small and extra‑large investors, though overall trend is slightly negative.
Fund Flow Rating
Analyst RatingBuy
Wall Street Opinions
Buy
Strong Buy
0%
Buy
75%
Hold
0%
Sell
0%
Strong Sell
0%
Glen SantangeloBuy
Date2026-02-24
InstitutionBarclays
Times predicted2
Historical Win Rate50.0%
Lisa GillNeutral
Stephen BaxterBuy
Steven James ValiquetteBuy
What is the analyst consensus for CAH?
- CAH holds a Bullish analyst rating, with 75% of experts assigning a Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 7.35/10 (Outperform).
